Private Advisor Group LLC Takes $610,000 Position in Invesco Pharmaceuticals ETF $PJP

Private Advisor Group LLC acquired a new position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,877 shares of the company’s stock, valued at approximately $610,000. Private Advisor Group LLC owned about 0.15% of Invesco Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. IFP Advisors Inc increased its stake in Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares during the last quarter. International Assets Investment Management LLC bought a new stake in Invesco Pharmaceuticals ETF during the fourth quarter worth about $64,000. Rockefeller Capital Management L.P. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 20.5% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after purchasing an additional 209 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 29.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,325 shares of the company’s stock worth $139,000 after purchasing an additional 300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Invesco Pharmaceuticals ETF during the 4th quarter valued at about $167,000.

Invesco Pharmaceuticals ETF Trading Up 1.0%

Shares of NYSEARCA PJP opened at $117.08 on Thursday. The stock has a market cap of $353.58 million, a price-to-earnings ratio of 15.59 and a beta of 0.45. Invesco Pharmaceuticals ETF has a 1-year low of $80.63 and a 1-year high of $122.69. The stock’s 50-day moving average is $112.41 and its 200 day moving average is $107.90.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.